The heparins and cancer: review of clinical trials and biological properties.

Castelli, Roberto; Porro, Fernando; Tarsia, Paolo

Castelli, Roberto; Porro, Fernando; Tarsia, Paolo.

Affiliation

Castelli R; Emergency Medicine Department, IRCCS Ospedale Maggiore di Milano, Milano, Italy. Castelli39@interfree.it

Vasc Med ; 9(3): 205-13, 2004 May.

Article in En | MEDLINE | ID: mdl-15675186

Subject(s)

Fibrinolytic Agents/therapeutic use; Heparin/pharmacology; Heparin/therapeutic use; Neoplasms/complications; Animals; Cell Proliferation/drug effects; Clinical Trials as Topic; Endothelial Cells/drug effects; Humans; Neovascularization, Pathologic/prevention & control; Pulmonary Embolism/etiology; Pulmonary Embolism/prevention & control; Thromboembolism/etiology; Thromboembolism/prevention & control; Vascular Endothelial Growth Factor A/drug effects; Vascular Endothelial Growth Factor A/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Heparin / Fibrinolytic Agents / Neoplasms Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Humans Language: En Journal: Vasc Med Journal subject: ANGIOLOGIA Year: 2004 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links